Anzeige
Mehr »
Montag, 30.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C9XF | ISIN: US0906556065 | Ticker-Symbol: 9OF
Frankfurt
27.06.25 | 15:29
1,400 Euro
+1,45 % +0,020
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIORESTORATIVE THERAPIES INC Chart 1 Jahr
5-Tage-Chart
BIORESTORATIVE THERAPIES INC 5-Tage-Chart

Aktuelle News zur BIORESTORATIVE THERAPIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.06.BioRestorative Therapies, Inc: BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates1
17.06.BioRestorative Therapies' Board Of Directors Authorizes Repurchase Of Up To $2 Mln Of Common Stock-
17.06.BioRestorative Therapies announces share repurchase program; shares gain over 8%3
17.06.BioRestorative Therapies, Inc: BioRestorative Announces Share Repurchase Program2
13.06.BioRestorative Therapies, Inc. - 8-K, Current Report1
13.06.BioRestorative berichtet über positive Daten aus Stammzellentherapie-Studie BRTX-1002
13.06.BioRestorative reports positive data from BRTX-100 stem cell therapy trial1
13.06.BioRestorative Therapies, Inc: BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 - an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease151- The International Society for Stem Cell Research ("ISSCR") 2025 Annual Meeting is the world's foremost gathering of stem cell and regenerative medicine leaders - - Updated data presented at ISSCR...
► Artikel lesen
BIORESTORATIVE THERAPIES Aktie jetzt für 0€ handeln
10.06.BioRestorative Therapies, Inc: BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team1
09.06.BioRestorative Therapies, Inc: BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 20251
14.05.BioRestorative Therapies, Inc. - 10-Q, Quarterly Report2
14.05.BioRestorative Therapies, Inc. - 8-K, Current Report2
13.05.Uncovering Potential: BioRestorative Therapies' Earnings Preview2
13.05.BioRestorative Therapies, Inc: Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data189MELVILLE, N.Y., May 13, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused...
► Artikel lesen
07.05.BioRestorative Therapies, Inc: BioRestorative to Present a BRTX-100 Clinical Update at ISCT 20251
21.04.BioRestorative Therapies, Inc. - 8-K, Current Report2
15.04.BioRestorative Therapies, Inc: BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities1
10.04.BioRestorative unaffected by new U.S. tariffs, continues clinical trials1
10.04.BioRestorative Therapies, Inc: BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States183MELVILLE, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused...
► Artikel lesen
27.03.BioRestorative Therapies GAAP EPS of -$1.16 beats by $0.07, revenue of $0.4M misses by $0.43M1
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1